A - Human Necessities – 61 – B
Patent
A - Human Necessities
61
B
A61B 5/055 (2006.01) G01N 24/08 (2006.01) G01N 33/483 (2006.01) G01N 33/50 (2006.01) G01N 33/92 (2006.01) G01R 33/46 (2006.01)
Patent
CA 2071638
2071638 9110128 PCTABS00006 A method is disclosed for predicting atherosclerotic risk in a living patient using nuclear magnetic resonance. Specifically, NMR parameters for protons of high density lipoproteins are determined and compared against a corresponding value for healthy patients. Suppression of the water proton signal is employed where necessary to obtain a suitable spectrum for the non-water component protons. Individuals with high atherosclerotic risk are identified based on the mean normalized high density lipoprotein resonance amplitude of a proton nuclear magnetic resonance spectrum of a chosen body fluid, most typically one's whole blood.
Fossel Eric T.
Mcdonagh Jan
Beth Israel Hospital Association (the)
Fossel Eric T.
Mcdonagh Jan
Smart & Biggar
LandOfFree
Method for predicting atherosclerotic risk does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for predicting atherosclerotic risk, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for predicting atherosclerotic risk will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1986003